# Pyxant Labs Inc: Form D filings

Pyxant Labs Inc, a biotechnology company in Colorado Springs, CO, filed 4 Form D notices with the SEC between 2014 and 2017. The latest, on July 13, 2017, reports $1.1 million sold of a $1.5 million offering to 17 investors.

Find out what Pyxant Labs Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Pyxant%20Labs%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Pyxant%20Labs%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fpyxant-labs-inc-1364214)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Pyxant%20Labs%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Pyxant%20Labs%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fpyxant-labs-inc-1364214)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Colorado](https://specstream.ai/data/form-d/state/colorado): 1,787 rows, by operating companies, filed since November 1, 2024, $89.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/colorado
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4720 FORGE RD, SUITE 108, Colorado Springs, CO, 80907
- Phone: (719) 593-1165
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Colorado
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b), Securities Act section 4(a)(5)
- SEC identifier (CIK): 1364214

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 13, 2017 | Amendment | $1,500,000 | $1,103,000 | $397,000 | 17 | Feb 1, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1364214/000136421417000001/0001364214-17-000001-index.htm) |
| Aug 3, 2016 | Amendment | $1,000,000 | $530,000 | $470,000 | 9 | Feb 1, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1364214/000136421416000003/0001364214-16-000003-index.htm) |
| Mar 1, 2016 | New notice | $650,000 | $440,000 | $210,000 | 6 | Feb 1, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1364214/000136421416000002/0001364214-16-000002-index.htm) |
| Mar 20, 2014 | New notice | $690,000 | $690,000 | $0 | 10 | Jan 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1364214/000136421414000003/0001364214-14-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Maurice A. Gaubatz | Executive Officer, Director |  |
| John A. Gloriod | Director |  |
| Lee A. Daniel III | Director |  |
| Jean A. Pineault | Executive Officer |  |
| Dean P. Stull | Director |  |
| Randall H. Guthrie | Executive Officer |  |

## Other biotechnology companies in Colorado that filed recently

- [HealthVest Fund V LLC](https://specstream.ai/data/form-d/company/healthvest-fund-v-llc-2163605) offering · Nov 5, 2026
- [GelSana Therapeutics, Inc.](https://specstream.ai/data/form-d/company/gelsana-therapeutics-inc-2002665) $4.4 million · Oct 8, 2026
- [Renovare Therapeutics, Inc.](https://specstream.ai/data/form-d/company/renovare-therapeutics-inc-2158361) $100,000 · Oct 2, 2026
- [EnteroTrack, LLC](https://specstream.ai/data/form-d/company/enterotrack-llc-1612812) $2 million · Sep 25, 2026

[Every Form D from the week of Jul 10, 2017](https://specstream.ai/data/form-d/week/2017-07-10) · [All recent filings in Colorado](https://specstream.ai/data/form-d/state/colorado) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Pyxant Labs Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).